Your browser doesn't support javascript.
loading
High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinib.
Fiala, Ondrej; Pesek, Milos; Finek, Jindrich; Topolcan, Ondrej; Racek, Jaroslav; Minarik, Marek; Benesova, Lucie; Bortlicek, Zbynek; Poprach, Alexandr; Buchler, Tomas.
Afiliação
  • Fiala O; Department of Oncology and Radiotherapy, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, alej Svobody 80, 304 60, Pilsen, Czech Republic. fiala.o@centrum.cz.
  • Pesek M; Biomedical Center, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic. fiala.o@centrum.cz.
  • Finek J; Department of Pneumology, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
  • Topolcan O; Department of Oncology and Radiotherapy, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, alej Svobody 80, 304 60, Pilsen, Czech Republic.
  • Racek J; Department of Nuclear Medicine, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
  • Minarik M; Institute of Clinical Biochemistry and Hematology, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
  • Benesova L; Center for Applied Genomics of Solid Tumours, Genomac Research Institute, Prague, Czech Republic.
  • Bortlicek Z; Department of Analytical Chemistry, Faculty of Sciences, Charles University in Prague, Pilsen, Czech Republic.
  • Poprach A; Institute of Clinical Biochemistry and Hematology, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
  • Buchler T; Institute of Biostatistics and Analysis, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Tumour Biol ; 36(12): 9215-22, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26088452
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína C-Reativa / Biomarcadores Tumorais / Carcinoma Pulmonar de Células não Pequenas / Cloridrato de Erlotinib Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína C-Reativa / Biomarcadores Tumorais / Carcinoma Pulmonar de Células não Pequenas / Cloridrato de Erlotinib Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article